Cite
HARVARD Citation
Tafelmeier, M. et al. (2020). Design of the SILICOFCM study: Effect of sacubitril/valsartan vs lifestyle intervention on functional capacity in patients with hypertrophic cardiomyopathy. Clinical cardiology. 43 (5), pp. 430-440. [Online].